- Titre
- The REQUITE-AB study: Validating predictive models and biomarkers of radiotherapy toxicity to reduce side-effects and improve quality of life in breast cancer patients
- Créateurs - sans rôle
- Tim Rattay - University of LeicesterKerstie Johnson - University of LeicesterSamuel Lavers - University of Leicester, Leicester, UKDavid Azria - University of Montpellier, Montpellier, FranceAkke Botma - German Cancer Research Center (DKFZ), Heidelberg, GermanyJenny Chang-Claude - German Cancer Research Center (DKFZ), Heidelberg, GermanySusan Davidson - The Christie NHS Foundation Trust, Manchester, UKDirk De Ruysscher - University Hospitals Leuven/KU Leuven, Leuven, BelgiumSara Gutiérrez Enrí quez - Vall d'Hebron Institute of Oncology, Barcelona, SpainPhillipe Lambin - Stichting Maastricht Radiation Oncology (Maastro), Maastricht, The NetherlandsTiziana Rancati - Fondazione IRCCS Istituto Nazionale dei TumoriBarry Rosenstein - Icahn School of Medicine at Mount SinaiChristopher Talbot - University of Leicester, Leicester, UKHubert Thierens - Universiteit Ghent, Ghent, BelgiumRicardo Valdagni - Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, ItalyAna Vega - Fundación Pública Galega Medicina Xenómica, Santiago de Compostela, SpainAdam Webb - University of LeicesterFrederik Wenz - German Cancer Research Center (DKFZ), Heidelberg, GermanyCatharine West - University of Manchester, Manchester, UKTom Burr - Source Bioscience, Nottingham, UKAlison Dunning - University of CambridgeR. Paul Symonds - University of Leicester, Leicester, UK
- Détails de publication
- European journal of surgical oncology, Vol.42(5), pp.S5-S5
- Éditeur
- Elsevier Ltd
- Identifiants
- 99141277909311
- Unité académique
- Institut de Recherche en Cancérologie de Montpellier - IRCM
- Langue
- English
- Type de ressource
- Journal article
Article de revue
The REQUITE-AB study: Validating predictive models and biomarkers of radiotherapy toxicity to reduce side-effects and improve quality of life in breast cancer patients
European journal of surgical oncology, Vol.42(5), pp.S5-S5
05/2016
Indicateurs
1 Consultations de la notice